These press releases are intended for business journalists and analysts/investors
Cervarix is approved for cervical cancer prevention in female population aged 9-45 years in mainland China
The age limit of Cervarixis approved to extend to 45 years, thereby benefiting more Chinese women
GSK announced today that Flixotide Nebules (generic name: Fluticasone Propionate Nebuliser Suspension) was officially launched in mainland China and provides a new option for the treatment of childhood asthma.
Today, the Chinese Association of STD and AIDS Prevention and Control (CASAPC; “the Association”) and GSK China launched the “Online Digital Physician Education Project” for AIDS prevention and control.